TD Securities analyst Aaron Bilkoski upgrades Range Resources (NYSE:RRC) from Hold to Buy and raises the price target from $32 to $33.
Cingulate Announces Master Services Agreement With Societal CDMO And Provides Clinical Update
Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation